… In this study, we evaluated risk factors for dry eye disease, intraocular pressure, and …
bronchodilators or corticosteroids via nebulizer but not inhaler is related to greater rates of dry eye. …

… It is advisable that an ophthalmologist consultation is sought for patients deemed to be at
risk for AACG before initiating on bronchodilator therapy. This may be feasible in selected …

… Inhaled and nasal glucocorticoids and the risks of ocular … The effect of nebulized
bronchodilator therapy on intraocular … Ocular hazards of nebulized bronchodilators. Postgrad Med …

… This study aimed to determine the reported risk of glaucoma, ocular hypertension (OHT) …
that assess ocular outcomes related to glaucoma in ICS and INS users. Study selection, risk of …

… the risk 7.49-fold for … Nebulizer delivery of steroids is associated with dry eye and cataracts.
Smoking, ageing, and long-term inhaled steroid use have all been linked to an increased risk …

… Maintenance use of inhaled bronchodilator(s) is the … of ICS added to dual bronchodilator
treatment in reducing the risk of … There was no clear evidence of increased risk for eye disorders …

… Oral or inhaled bronchodilators and systemic steroid were similarly used in both groups …
according to the visual sum score in bronchiectasis on chest CT and the risk of pneumonia. …

… Both systemic and inhaled corticosteroids may increase the risk … corticosteroid exposure
and the risk of cataract development. … Pooled analyses revealed on average a doubled risk of …

… risk of serious exacerbations 1 . In contrast, there is much debate about the role of ICS relative
to long-acting inhaled bronchodilators, … bruising, as well as ocular adverse effects such as …

… Use of various drugs (other than bronchodilators and inhaled corticosteroids) by nebulized
… of aerosol leading to significant facial and eye deposition This risk is mitigated by using a …